The specialist coverage layer hospitals plug into - an EHR-integrated, AI-enabled platform that beams board-certified physicians into emergency rooms that could never recruit them locally.
A patient arrives slurring words, one arm gone heavy. The clock that matters in a stroke is measured in minutes, and the nearest specialist is a long ambulance ride or a longer wait. In hundreds of hospitals like this one, the night nurse does not call a colleague down the hall. She opens AmplifyMD, and a board-certified neurologist appears on a screen, chart already loaded, ready to make the call that saves brain tissue.
This is AmplifyMD in 2026: a quietly large company of roughly 63 people in Los Gatos, California, running an EHR-integrated, AI-enabled virtual care platform that now powers more than 400 active programs across every U.S. state and handles north of 220,000 consults a year. It is not a doctor-on-an-app for sniffles. It is the infrastructure hospitals lease when they cannot afford to build a specialty department from scratch.
"AmplifyMD isn't just enabling telehealth - it's reimagining how health systems leverage their clinical resources."
Every other industry got faster and cheaper by adding technology and scale. Healthcare mostly got a fax machine. The result is a stubborn geography problem: neurologists, psychiatrists, infectious-disease physicians and intensivists cluster in big cities, while the rural and community hospitals that need them most cannot recruit, afford, or retain them. A patient's odds can come down to a zip code.
So hospitals do the expensive thing. They transfer patients by ambulance to facilities that have the right doctor, draining beds, budgets, and time the patient does not have. Or they keep a specialist on a pricey on-call contract who covers one site and sits idle between emergencies. Neither scales. Both leak money. And the patient, the one person who never reads the org chart, waits.
"If technology transformed other industries through efficiency and scale, why couldn't we use it to do the same for healthcare?"
That question is the tension running through everything the company has built. Specialist time is the scarcest resource in medicine. AmplifyMD's whole wager is that the scarcity is largely an allocation problem - and allocation is something software is unusually good at.
In 2019, Meena Mallipeddi and Anand Nathan founded AmplifyMD to attack specialist access head-on. Mallipeddi took the CEO seat; Nathan became Chief Product Officer. Their bet was contrarian for the telehealth boom around them: the win would not come from yet another video-visit app, but from plumbing - deep integration into the electronic health records hospitals already live inside, paired with a national network of specialists who could be routed wherever and whenever demand spiked.
The thesis attracted the kind of investors who like infrastructure. Forerunner Ventures and Greylock Partners co-led an early round; F-Prime Capital led a $23 million Series A in March 2022. The founders kept the company lean and the focus narrow - acute and specialty coverage for health systems, not a sprawling consumer play.
"Health systems using our platform are proving it's possible to deliver care that is faster and more sustainable."
It is a tidy irony of telemedicine that the hard part was never the video call. Anyone can do a video call. The hard part is the chart, the workflow, the billing, the credentialing across 50 states, and getting a specialist into the right ED at the right second. That unglamorous middle layer is exactly where AmplifyMD planted its flag.
AmplifyMD is two things welded together. One is software that lives inside the hospital's existing EHR, using intelligent automation and embedded AI to orchestrate who gets seen, by whom, and how fast. The other is a nationwide bench of board-certified physicians across more than 15 fields, available on demand. The hospital does not hire the doctor. It taps the network.
EHR-integrated, AI-enabled software to launch, manage and scale telehealth programs - with workflow orchestration doing the routing.
On-demand access to board-certified physicians across 15+ essential fields, extending capacity without local recruiting.
Rapid virtual neurology for time-sensitive cases, cutting door-to-decision time and avoiding costly transfers.
Virtual hospitalist support that doubles consults handled per shift and steadies overnight coverage.
In September 2025, AmplifyMD closed a $20 million Series B led by Forerunner Ventures, with F-Prime, Greylock and Tau Ventures returning - and Memorial Hermann Health System joining as a strategic investor. That last detail is the tell. Memorial Hermann does not just fund AmplifyMD; it uses the platform. A health system putting its own capital behind a vendor it relies on is the rare endorsement that cannot be bought with a marketing budget.
"AmplifyMD stands out because it combines AI-enabled workflows with on-demand specialty coverage."
There is also the small matter of the trophy case. AmplifyMD has been named Best Overall Telemedicine Platform in the MedTech Breakthrough Awards two years in a row - a program that drew more than 5,000 nominations in its 2026 cycle. Specialty wait times that once stretched into months, the company reports, now compress into days. Same doctors. Different math.
"AmplifyMD reduced TeleStroke operational costs by 52% while doubling hospitalist cross-cover consults per shift."
"Specialty care wait times dropped from months to days."
Strip away the dashboards and the funding rounds and AmplifyMD's mission is plain: improve access to physician specialists, especially for rural and underserved communities, through virtual specialty care that actually works inside a hospital's existing systems. The company runs on five stated values - Integrity, Empathy, Responsiveness, Flexibility, Results - and a distributed, remote-friendly team that keeps the headcount small and the footprint national.
The leadership reads like people who have been inside the problem: CEO Meena Mallipeddi, named to Inc.'s Female Founders 250 and tapped by the Forbes Technology Council as a top health-tech CEO to watch; Chief Medical Officer Mohan Mallipeddi, MD; CPO and co-founder Anand Nathan; plus a bench of commercial, clinical and operations leaders. The pitch is not utopian. It is logistical - put the right doctor in front of the right patient, regardless of the map.
Health systems are squeezed from both ends - more patients, fewer clinicians, thinner margins. The fashionable answer is to bolt AI onto everything and hope. AmplifyMD's argument, made plainly in its own writing, is that the real throughput gains come from orchestration: routing scarce clinical attention to where it counts, in the workflow where the work already happens. AI helps. Coordination wins.
"The next gains in hospital throughput won't come from AI - they'll come from orchestration."
Which brings us back to that small hospital at 3 a.m. The neurologist still lives 200 miles away. Nothing about geography has changed. What has changed is that the distance no longer decides the outcome. The night nurse opens a screen, the specialist appears, the clot is treated, the patient keeps the use of their arm - and the ambulance that would have carried them out of town stays parked. AmplifyMD did not move the doctor closer. It made the distance stop mattering. For a company built on one stubborn question, that is the whole answer.